Copied
 
 
2022, DKK
21.06.2023
Bruttoresultat

3.808'

Primær drift

969'

Årets resultat

371'

Aktiver

6.936'

Kortfristede aktiver

6.256'

Egenkapital

5.988'

Afkastningsgrad

14 %

Soliditetsgrad

86 %

Likviditetsgrad

+500%

Resultat
21.06.2023
Årsrapport
2022
21.06.2023
2021
21.06.2022
2020
30.06.2021
2019
02.06.2020
2018
18.06.2019
2017
29.06.2018
2016
19.06.2017
2015
06.07.2016
Nettoomsætning
Bruttoresultat3.808.4862.460.9022.162.0731.197.878508.435-118.014345.7681.280.962
Resultat af primær drift969.336-25.392-10.175-299.369-9.827-211.010275.7150
Indtægter af kapitalandele (tilknyttede og associerede) 00000000
Finansielle indtægter130.496618.667246.678145.31339.45412.019156.3060
Finansieringsomkostninger-624.460-93.939-203.225-11.170-213.179-165.087-61.406408.567
Andre finansielle omkostninger00000000
Resultat før skat475.372499.33633.278-165.226-183.552-364.078370.615965.592
Resultat370.764389.231101.527-165.226-193.972-268.409284.421883.757
Forslag til udbytte00000000
Aktiver
21.06.2023
Årsrapport
2022
21.06.2023
2021
21.06.2022
2020
30.06.2021
2019
02.06.2020
2018
18.06.2019
2017
29.06.2018
2016
19.06.2017
2015
06.07.2016
Kortfristede varebeholdninger1.452.8361.547.893915.119652.969531.179720.274396.287643.624
Kortfristede tilgodehavender fra salg og tjenesteydelser 3.735.4752.839.4383.448.1212.480.4312.768.5652.372.2945.101.1342.283.607
Likvider130.916214.959788.891970.7321.037.1601.200.54271.9122.514.659
Kortfristede aktiver6.256.4276.040.0345.990.9554.733.4844.827.9444.943.5106.245.5335.980.390
Immaterielle aktiver og goodwill639.436788.769938.103888.161859.051811.841762.493470.701
Finansielle anlægsaktiver39.83235.00831.63730.86530.11323.60622.76122.761
Materielle aktiver00000000
Langfristede aktiver679.268823.777969.740919.026889.164835.447785.254493.462
Aktiver6.935.6956.863.8116.960.6955.652.5105.717.1085.778.9577.030.7876.473.852
Aktiver
21.06.2023
Passiver
21.06.2023
Årsrapport
2022
21.06.2023
2021
21.06.2022
2020
30.06.2021
2019
02.06.2020
2018
18.06.2019
2017
29.06.2018
2016
19.06.2017
2015
06.07.2016
Forslag til udbytte00000000
Egenkapital5.988.3735.617.6095.228.3785.134.4285.299.6535.493.6255.762.0345.477.613
Hensatte forpligtelser140.67653.712000085.2490
Langfristet gæld til banker00000000
Anden langfristet gæld00000000
Leverandører af varer og tjenesteydelser674.929600.666866.32669.667234.821148.820272.291429.699
Kortfristede forpligtelser806.6461.192.4901.732.317518.082417.455285.3321.183.5040
Gældsforpligtelser806.6461.192.4901.732.317518.082417.455285.3321.183.504996.239
Forpligtelser806.6461.192.4901.732.317518.082417.455285.3321.183.504996.239
Passiver6.935.6956.863.8116.960.6955.652.5105.717.1085.778.9577.030.7876.473.852
Passiver
21.06.2023
Nøgletal
21.06.2023
Årsrapport
2022
21.06.2023
2021
21.06.2022
2020
30.06.2021
2019
02.06.2020
2018
18.06.2019
2017
29.06.2018
2016
19.06.2017
2015
06.07.2016
Afkastningsgrad 14,0 %-0,4 %-0,1 %-5,3 %-0,2 %-3,7 %3,9 %Na.
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 6,2 %6,9 %1,9 %-3,2 %-3,7 %-4,9 %4,9 %16,1 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal 155,2 %-27,0 %-5,0 %-2.680,1 %-4,6 %-127,8 %449,0 %Na.
Soliditestgrad 86,3 %81,8 %75,1 %90,8 %92,7 %95,1 %82,0 %84,6 %
Likviditetsgrad 775,6 %506,5 %345,8 %913,7 %1.156,5 %1.732,5 %527,7 %Na.
Resultat
21.06.2023
Gæld
21.06.2023
Årsrapport
21.06.2023
Nyeste:01.01.2022- 31.12.2022(offentliggjort: 21.06.2023)
Information om virksomhedens regnskabsklasse:The annual report for TannerMedico A/S has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises. The accounting policies are unchanged from last year, and the annual report is presented in DKK.
Oplysning om pantsætninger og sikkerhedsstillelser:7. Charges and security For bank loans, DKK 10.411, the company has provided security in company assets representing a nominal value of DKK 1.000.000. This security comprises the assets below, stating the carrying amounts: DKK in thousands Trade receivables 3.246
Beretning
21.06.2023
Dato for ledelsens godkendelse af årsrapporten:2023-06-19
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Managing Director have approved the annual report of TannerMedico A/S for the financial year 1 January - 31 December 2022.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:The principal activities of the company TannerMedico A/S manufactures and internationally distributes products within the sleep category, including Asonor Anti Snoring Solution and Asonor Sleep Support. Asonor Anti Snoring Solution complies with Medical Device Regulations and manufactures according to EU GMP and ISO 13485. Asonor Sleep Support is a food supplement that naturally contributes to better sleep and complies with EU regulations. TannerMedico A/S markets its products worldwide through pharmacies and online platforms. We remain committed to expanding our market reach, increasing our product offerings, and prioritizing quality and regulatory compliance in all our activities.